A recent review shows who newer medications for type 2 diabetes may help the most, particularly in reducing the risk of cardiovascular disease.

Altimmune, Inc. (NASDAQ:ALT), a biopharmaceutical company with a market capitalization of $503.56 million focused on ...

The following is a summary of “Metabolic Effects of Glucagon Stimulations in Type 1 Diabetes and Healthy Controls,” published ...

We thought this was all being regulated in the liver because that's where glucagon exerts its function. But our data kept telling us that everything of importance was happening between the ...

“We thought this was all being regulated in the liver because that’s where glucagon exerts its function,” recalls Veiga-Fernandes. “But our data kept telling us that everything of ...

“We thought this was all being regulated in the liver because that’s where glucagon exerts its function”, recalls Veiga-Fernandes. “But our data kept telling us that everything of ...

"We thought this was all being regulated in the liver because that's where glucagon exerts its function," recalls Veiga-Fernandes. "But our data kept telling us that everything of importance was ...

It performs both exocrine and endocrine functions. The exocrine cells release digestive enzymes to assist with breaking down food. The endocrine cells release insulin and glucagon, two hormones that ...

Due to the risk of unpredictable symptoms and the liver's compromised function impacting blood sugar levels, consistent blood glucose monitoring is especially crucial for patients with diabetes and ...

Health care professionals should explore the use of glucagon-like peptide-1 receptor agonists (GLP1RAs) for cardiovascular risk reduction and their broader impacts on cardiometabolic health beyond ...